
It has been demonstrated that zzso zzso has zzso activity in human zzso zzso models in zzso and in zzso The objective of this study was to evaluate the safety and efficacy of zzso in patients with zzso zzso zzso zzso Fifteen patients with zzso zzso zzso who had received prior surgery, zzso and zzso lines of zzso chemotherapy were zzso zzso (16 zzso was administered zzso for 3 h every 21 zzso The primary end point was six months zzso survival zzso secondary end points were safety, zzso response rate, and median time to progression zzso zzso resonance imaging zzso evaluations were performed every two cycles and toxicity was evaluated at each cycle using common zzso criteria for adverse events zzso zzso A median of four cycles was zzso The median zzso was 13 zzso zzso was achieved in five patients zzso three with zzso zzso and two with zzso zzso The most common zzso adverse event was zzso which occurred in zzso zzso zzso had an acceptable safety profile and clinically relevant activity in patients with zzso zzso zzso zzso 

